We have an emerging new entrant in the increasingly crowded weight loss drug space.

Medicare Part D will cover popular weight loss drugs like Wegovy and Ozempic starting in 2026, with copays capped at $50 per ...

The World Health Organization issued new guidance this week on the use of popular GLP-1 drugs, like Ozempic, Wegovy, Mounjaro ...

Serena Williams, the 23-time Grand Slam tennis champion, has taken the first step toward a potential comeback by reentering ...

Uncover common misconceptions about GLP-1s for weight loss. Learn the importance of diet, exercise, managing side effects, ...

For a 45-year-old who pays out of pocket for Wegovy, the cost comes to $3,900 a year - even with the discounts. For a Medicare beneficiary, that cost will be $600 a year in copays. But some research ...

As a work of reportage, Off the Scales does a wonderful job of explaining the origins of Ozempic and other GLP-1 drugs and ...

Pennsylvania has quietly moved to limit access next year to popular weight-loss drugs like Ozempic and Wegovy for residents ...

Influencer Sabrina Chazen says she struggled emotionally when the GLP-1 drug she tried didn't lead to significant weight loss ...

The health agency supports the long-term use of the medications in combination with a healthy diet and exercise, and calls ...

Altimmune, Inc. nears key MASH data for pemvidutide—learn investor risks, potential rewards, and what the upcoming results ...

They’re definitely easier and more affordable than injectables, but do they work as well? Here’s what you need to know.